{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:14:50Z","timestamp":1758759290352,"version":"3.44.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","award":["CBF-2025-I-25"],"award-info":[{"award-number":["CBF-2025-I-25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00280-025-04815-3","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:30:00Z","timestamp":1758609000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic treatment with carboplatin induces mechanical hypersensitivity and neurochemical changes in the mouse dorsal root ganglia and spinal cord"],"prefix":"10.1007","volume":"95","author":[{"given":"Arisai","family":"Mart\u00ednez-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizeth Yazmin","family":"Ponce-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2836-7424","authenticated-orcid":false,"given":"Juan Antonio","family":"Vazquez-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Yanneth","family":"Ram\u00edrez-Quintanilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor Fabi\u00e1n","family":"Torres-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2703-9736","authenticated-orcid":false,"given":"Juan Miguel","family":"Jim\u00e9nez-Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"8","key":"4815_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7(8):573\u2013584. https:\/\/doi.org\/10.1038\/nrc2167","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4815_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2165\/00003495-198937020-00005","volume":"37","author":"AJ Wagstaff","year":"1989","unstructured":"Wagstaff AJ, Ward A, Benfield P, Heel RC (1989) Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs 37(2):162\u2013190. https:\/\/doi.org\/10.2165\/00003495-198937020-00005","journal-title":"Drugs"},{"key":"4815_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102203","volume":"79","author":"LK Dillard","year":"2022","unstructured":"Dillard LK, Lopez-Perez L, Martinez RX, Fullerton AM, Chadha S, McMahon CM (2022) Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: a systematic review and meta-analysis. Cancer Epidemiol 79:102203. https:\/\/doi.org\/10.1016\/j.canep.2022.102203","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"4815_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.4103\/1673-5374.276321","volume":"15","author":"A Lazic","year":"2020","unstructured":"Lazic A, Popovic J, Paunesku T, Woloschak GE, Stevanovic M (2020) Insights into platinum-induced peripheral neuropathy-current perspective. Neural Regen Res 15(9):1623\u20131630. https:\/\/doi.org\/10.4103\/1673-5374.276321","journal-title":"Neural Regen Res"},{"issue":"1","key":"4815_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.seminoncol.2005.12.010","volume":"33","author":"FH Hausheer","year":"2006","unstructured":"Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F (2006) Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33(1):15\u201349. https:\/\/doi.org\/10.1053\/j.seminoncol.2005.12.010","journal-title":"Semin Oncol"},{"issue":"5","key":"4815_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/01658107.2017.1419367","volume":"42","author":"SM Stevens","year":"2018","unstructured":"Stevens SM, McClelland CM, Trusheim JE, Lee MS (2018) Carboplatin-associated cranial neuropathy. Neuroophthalmology 42(5):302\u2013305. https:\/\/doi.org\/10.1080\/01658107.2017.1419367","journal-title":"Neuroophthalmology"},{"issue":"4","key":"4815_CR7","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1054\/bjoc.1999.1026","volume":"82","author":"D Screnci","year":"2000","unstructured":"Screnci D, McKeage MJ, Galettis P, Hambley TW, Palmer BD, Baguley BC (2000) Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer 82(4):966\u2013972. https:\/\/doi.org\/10.1054\/bjoc.1999.1026","journal-title":"Br J Cancer"},{"issue":"9","key":"4815_CR8","doi-asserted-by":"publisher","first-page":"e106485","DOI":"10.1371\/journal.pone.0106485","volume":"9","author":"MR Kelley","year":"2014","unstructured":"Kelley MR, Jiang Y, Guo C, Reed A, Meng H, Vasko MR (2014) Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy. PLoS ONE 9(9):e106485. https:\/\/doi.org\/10.1371\/journal.pone.0106485","journal-title":"PLoS ONE"},{"key":"4815_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1744-8069-4-10","volume":"4","author":"JM Jimenez-Andrade","year":"2008","unstructured":"Jimenez-Andrade JM, Herrera MB, Ghilardi JR, Vardanyan M, Melemedjian OK, Mantyh PW (2008) Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies. Mol Pain 4:10. https:\/\/doi.org\/10.1186\/1744-8069-4-10","journal-title":"Mol Pain"},{"issue":"1","key":"4815_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1365-2990.1999.00160.x","volume":"25","author":"A Krarup-Hansen","year":"1999","unstructured":"Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rorth M, Schmalbruch H (1999) Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 25(1):29\u201340. https:\/\/doi.org\/10.1046\/j.1365-2990.1999.00160.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"4815_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1023\/a:1008231925889","volume":"9","author":"G Cavaletti","year":"1998","unstructured":"Cavaletti G, Fabbrica D, Minoia C, Frattola L, Tredici G (1998) Carboplatin toxic effects on the peripheral nervous system of the rat. Ann Oncol 9(4):443\u2013447. https:\/\/doi.org\/10.1023\/a:1008231925889","journal-title":"Ann Oncol"},{"issue":"4","key":"4815_CR12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00280-009-1017-6","volume":"64","author":"JJ Liu","year":"2009","unstructured":"Liu JJ, Jamieson SM, Subramaniam J, Ip V, Jong NN, Mercer JF et al (2009) Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity. Cancer Chemother Pharmacol 64(4):847\u2013856. https:\/\/doi.org\/10.1007\/s00280-009-1017-6","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4815_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00280-013-2304-9","volume":"73","author":"HJ Park","year":"2014","unstructured":"Park HJ, Stokes JA, Corr M, Yaksh TL (2014) Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 73(1):25\u201334. https:\/\/doi.org\/10.1007\/s00280-013-2304-9","journal-title":"Cancer Chemother Pharmacol"},{"key":"4815_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092218","author":"SJ Cho","year":"2023","unstructured":"Cho SJ, Lee JY, Jeong Y, Cho SY, Lee DG, Choi JY (2023) Milnacipran has an antihyperalgesic effect on cisplatin-induced neuropathy. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15092218","journal-title":"Pharmaceutics"},{"issue":"12","key":"4815_CR15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jpain.2013.08.002","volume":"14","author":"L Di Cesare Mannelli","year":"2013","unstructured":"Di Cesare Mannelli L, Pacini A, Bonaccini L, Zanardelli M, Mello T, Ghelardini C (2013) Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J Pain 14(12):1585\u20131600. https:\/\/doi.org\/10.1016\/j.jpain.2013.08.002","journal-title":"J Pain"},{"issue":"1","key":"4815_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/jns.12307","volume":"24","author":"CA Miguel","year":"2019","unstructured":"Miguel CA, Raggio MC, Villar MJ, Gonzalez SL, Coronel MF (2019) Anti-allodynic and anti-inflammatory effects of 17alpha-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy. J Peripher Nerv Syst 24(1):100\u2013110. https:\/\/doi.org\/10.1111\/jns.12307","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"4815_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/exnr.1996.0050","volume":"138","author":"I Barajon","year":"1996","unstructured":"Barajon I, Bersani M, Quartu M, Del Fiacco M, Cavaletti G, Holst JJ et al (1996) Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp Neurol 138(1):93\u2013104. https:\/\/doi.org\/10.1006\/exnr.1996.0050","journal-title":"Exp Neurol"},{"issue":"1","key":"4815_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12640-023-00685-w","volume":"42","author":"S Xie","year":"2024","unstructured":"Xie S, Gao Z, Zhang J, Xing C, Dong Y, Wang L et al (2024) Monoclonal antibody targeting CGRP relieves Cisplatin-induced neuropathic pain by attenuating neuroinflammation. Neurotox Res 42(1):8. https:\/\/doi.org\/10.1007\/s12640-023-00685-w","journal-title":"Neurotox Res"},{"issue":"1","key":"4815_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","volume":"203","author":"CM Peters","year":"2007","unstructured":"Peters CM, Jimenez-Andrade JM, Jonas BM, Sevcik MA, Koewler NJ, Ghilardi JR et al (2007) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203(1):42\u201354. https:\/\/doi.org\/10.1016\/j.expneurol.2006.07.022","journal-title":"Exp Neurol"},{"key":"4815_CR20","doi-asserted-by":"publisher","unstructured":"Hain BA, Xu H, Wilcox JR, Mutua D, Waning DL (2019) Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia. JCSM Rapid Communications 2(1):e00075. https:\/\/doi.org\/10.1002\/j.2617-1619.2019.tb00011.x","DOI":"10.1002\/j.2617-1619.2019.tb00011.x"},{"key":"4815_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1744-8069-10-56","volume":"10","author":"J Guindon","year":"2014","unstructured":"Guindon J, Deng L, Fan B, Wager-Miller J, Hohmann AG (2014) Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status. Mol Pain 10:56. https:\/\/doi.org\/10.1186\/1744-8069-10-56","journal-title":"Mol Pain"},{"issue":"1","key":"4815_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"issue":"1","key":"4815_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2004.11.028","volume":"193","author":"CM Peters","year":"2005","unstructured":"Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM et al (2005) Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 193(1):85\u2013100. https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.028","journal-title":"Exp Neurol"},{"issue":"2","key":"4815_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/cne.21311","volume":"502","author":"R Ruscheweyh","year":"2007","unstructured":"Ruscheweyh R, Forsthuber L, Schoffnegger D, Sandkuhler J (2007) Modification of classical neurochemical markers in identified primary afferent neurons with Abeta-, Adelta-, and C-fibers after chronic constriction injury in mice. J Comp Neurol 502(2):325\u2013336. https:\/\/doi.org\/10.1002\/cne.21311","journal-title":"J Comp Neurol"},{"issue":"29","key":"4815_CR25","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1523\/JNEUROSCI.0404-23.2023","volume":"43","author":"M Diaz-delCastillo","year":"2023","unstructured":"Diaz-delCastillo M, Palasca O, Nemler TT, Thygesen DM, Chavez-Saldana NA, Vazquez-Mora JA et al (2023) Metastatic infiltration of nervous tissue and periosteal nerve sprouting in multiple myeloma-induced bone pain in mice and human. J Neurosci 43(29):5414\u20135430. https:\/\/doi.org\/10.1523\/JNEUROSCI.0404-23.2023","journal-title":"J Neurosci"},{"issue":"10","key":"4815_CR26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/cne.23749","volume":"523","author":"J Su","year":"2015","unstructured":"Su J, Gao T, Shi T, Xiang Q, Xu X, Wiesenfeld-Hallin Z et al (2015) Phenotypic changes in dorsal root ganglion and spinal cord in the collagen antibody-induced arthritis mouse model. J Comp Neurol 523(10):1505\u20131528. https:\/\/doi.org\/10.1002\/cne.23749","journal-title":"J Comp Neurol"},{"key":"4815_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainres.2007.06.066","volume":"1168","author":"CM Peters","year":"2007","unstructured":"Peters CM, Jimenez-Andrade JM, Kuskowski MA, Ghilardi JR, Mantyh PW (2007) An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of Paclitaxel in the rat. Brain Res 1168:46\u201359. https:\/\/doi.org\/10.1016\/j.brainres.2007.06.066","journal-title":"Brain Res"},{"issue":"10","key":"4815_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.sc.3102020","volume":"45","author":"AD Ackery","year":"2007","unstructured":"Ackery AD, Norenberg MD, Krassioukov A (2007) Calcitonin gene-related peptide immunoreactivity in chronic human spinal cord injury. Spinal Cord 45(10):678\u2013686. https:\/\/doi.org\/10.1038\/sj.sc.3102020","journal-title":"Spinal Cord"},{"key":"4815_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052356","author":"M Antal","year":"2025","unstructured":"Antal M (2025) Molecular anatomy of synaptic and extrasynaptic neurotransmission between nociceptive primary afferents and spinal dorsal horn neurons. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26052356","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4815_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/j.pain.0000000000000407","volume":"157","author":"N Iwagaki","year":"2016","unstructured":"Iwagaki N, Ganley RP, Dickie AC, Polgar E, Hughes DI, Del Rio P et al (2016) A combined electrophysiological and morphological study of neuropeptide Y-expressing inhibitory interneurons in the spinal dorsal horn of the mouse. Pain 157(3):598\u2013612. https:\/\/doi.org\/10.1097\/j.pain.0000000000000407","journal-title":"Pain"},{"key":"4815_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2008.05.004","volume":"1219","author":"A Romero-Sandoval","year":"2008","unstructured":"Romero-Sandoval A, Chai N, Nutile-McMenemy N, Deleo JA (2008) A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res 1219:116\u2013126. https:\/\/doi.org\/10.1016\/j.brainres.2008.05.004","journal-title":"Brain Res"},{"key":"4815_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133271","author":"K Miyano","year":"2019","unstructured":"Miyano K, Shiraishi S, Minami K, Sudo Y, Suzuki M, Yokoyama T (2019) Carboplatin enhances the activity of human transient receptor potential Ankyrin 1 through the Cyclic AMP-Protein kinase A-A-kinase anchoring protein (AKAP) pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20133271","journal-title":"Int J Mol Sci"},{"key":"4815_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136863","volume":"788","author":"CA Miguel","year":"2022","unstructured":"Miguel CA, Noya-Riobo MV, Brumovsky PR, Villar MJ, Coronel MF (2022) Sex-related differences in oxaliplatin-induced changes in the expression of transient receptor potential channels and their contribution to cold hypersensitivity. Neurosci Lett 788:136863. https:\/\/doi.org\/10.1016\/j.neulet.2022.136863","journal-title":"Neurosci Lett"},{"issue":"7","key":"4815_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.pain.2011.02.051","volume":"152","author":"R Nassini","year":"2011","unstructured":"Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N et al (2011) Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain 152(7):1621\u20131631. https:\/\/doi.org\/10.1016\/j.pain.2011.02.051","journal-title":"Pain"},{"issue":"5","key":"4815_CR35","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.69424","volume":"12","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu C, Gao X, Yao Q (2022) Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics 12(5):2115\u20132132. https:\/\/doi.org\/10.7150\/thno.69424","journal-title":"Theranostics"},{"issue":"2","key":"4815_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/mcne.1999.0814","volume":"15","author":"H Tsujino","year":"2000","unstructured":"Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K et al (2000) Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Mol Cell Neurosci 15(2):170\u2013182. https:\/\/doi.org\/10.1006\/mcne.1999.0814","journal-title":"Mol Cell Neurosci"},{"issue":"30","key":"4815_CR37","doi-asserted-by":"publisher","first-page":"7911","DOI":"10.1523\/JNEUROSCI.5313-06.2007","volume":"27","author":"R Seijffers","year":"2007","unstructured":"Seijffers R, Mills CD, Woolf CJ (2007) Atf3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J Neurosci 27(30):7911\u20137920. https:\/\/doi.org\/10.1523\/JNEUROSCI.5313-06.2007","journal-title":"J Neurosci"},{"key":"4815_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134378","volume":"709","author":"AF Pereira","year":"2019","unstructured":"Pereira AF, Pereira LMS, Silva CMP, Freitas Alves BW, Barbosa JS, Pinto FMM et al (2019) Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice. Neurosci Lett 709:134378. https:\/\/doi.org\/10.1016\/j.neulet.2019.134378","journal-title":"Neurosci Lett"},{"issue":"3","key":"4815_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pain.2006.09.016","volume":"128","author":"B Ling","year":"2007","unstructured":"Ling B, Authier N, Balayssac D, Eschalier A, Coudore F (2007) Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain 128(3):225\u2013234. https:\/\/doi.org\/10.1016\/j.pain.2006.09.016","journal-title":"Pain"},{"issue":"1","key":"4815_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.410310114","volume":"31","author":"SC Apfel","year":"1992","unstructured":"Apfel SC, Arezzo JC, Lipson L, Kessler JA (1992) Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31(1):76\u201380. https:\/\/doi.org\/10.1002\/ana.410310114","journal-title":"Ann Neurol"},{"issue":"1","key":"4815_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0014-4886(95)90054-3","volume":"132","author":"Y Schmidt","year":"1995","unstructured":"Schmidt Y, Unger JW, Bartke I, Reiter R (1995) Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db\/db) mice. Exp Neurol 132(1):16\u201323. https:\/\/doi.org\/10.1016\/0014-4886(95)90054-3","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"4815_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3940(90)90696-7","volume":"108","author":"K Noguchi","year":"1990","unstructured":"Noguchi K, Senba E, Morita Y, Sato M, Tohyama M (1990) Co-expression of alpha-CGRP and beta-CGRP mrnas in the rat dorsal root ganglion cells. Neurosci Lett 108(1\u20132):1\u20135. https:\/\/doi.org\/10.1016\/0304-3940(90)90696-7","journal-title":"Neurosci Lett"},{"issue":"9","key":"4815_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/00007632-200105010-00005","volume":"26","author":"S Ohtori","year":"2001","unstructured":"Ohtori S, Takahashi K, Chiba T, Yamagata M, Sameda H, Moriya H (2001) Phenotypic inflammation switch in rats shown by calcitonin gene-related peptide immunoreactive dorsal root ganglion neurons innervating the lumbar facet joints. Spine (Phila Pa 1976) 26(9):1009\u20131013. https:\/\/doi.org\/10.1097\/00007632-200105010-00005","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"4815_CR44","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1055\/s-2007-978748","volume":"31","author":"T Hokfelt","year":"1999","unstructured":"Hokfelt T, Broberger C, Diez M, Xu ZQ, Shi T, Kopp J et al (1999) Galanin and NPY, two peptides with multiple putative roles in the nervous system. Horm Metab Res 31(5):330\u2013334. https:\/\/doi.org\/10.1055\/s-2007-978748","journal-title":"Horm Metab Res"},{"key":"4815_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroscience.2017.08.044","volume":"363","author":"KA Boyle","year":"2017","unstructured":"Boyle KA, Gutierrez-Mecinas M, Polgar E, Mooney N, O\u2019Connor E, Furuta T et al (2017) A quantitative study of neurochemically defined populations of inhibitory interneurons in the superficial dorsal Horn of the mouse spinal cord. Neuroscience 363:120\u2013133. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.08.044","journal-title":"Neuroscience"},{"issue":"2","key":"4815_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jpain.2012.11.002","volume":"14","author":"SY Yoon","year":"2013","unstructured":"Yoon SY, Robinson CR, Zhang H, Dougherty PM (2013) Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J Pain 14(2):205\u2013214. https:\/\/doi.org\/10.1016\/j.jpain.2012.11.002","journal-title":"J Pain"},{"issue":"1","key":"4815_CR47","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1213\/ANE.0b013e31826e1007","volume":"116","author":"HJ Park","year":"2013","unstructured":"Park HJ, Stokes JA, Pirie E, Skahen J, Shtaerman Y, Yaksh TL (2013) Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept. Anesth Analg 116(1):224\u2013231. https:\/\/doi.org\/10.1213\/ANE.0b013e31826e1007","journal-title":"Anesth Analg"},{"key":"4815_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2017.10.011","volume":"68","author":"LY Hu","year":"2018","unstructured":"Hu LY, Zhou Y, Cui WQ, Hu XM, Du LX, Mi WL et al (2018) Triggering receptor expressed on myeloid cells 2 (TREM2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice. Brain Behav Immun 68:132\u2013145. https:\/\/doi.org\/10.1016\/j.bbi.2017.10.011","journal-title":"Brain Behav Immun"},{"key":"4815_CR49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2014.05.051","volume":"274","author":"CR Robinson","year":"2014","unstructured":"Robinson CR, Zhang H, Dougherty PM (2014) Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat. Neuroscience 274:308\u2013317. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.05.051","journal-title":"Neuroscience"},{"key":"4815_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","volume":"261","author":"L Di Cesare Mannelli","year":"2014","unstructured":"Di Cesare Mannelli L, Pacini A, Micheli L, Tani A, Zanardelli M, Ghelardini C (2014) Glial role in oxaliplatin-induced neuropathic pain. Exp Neurol 261:22\u201333. https:\/\/doi.org\/10.1016\/j.expneurol.2014.06.016","journal-title":"Exp Neurol"},{"issue":"1","key":"4815_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41467-019-13839-2","volume":"11","author":"X Yu","year":"2020","unstructured":"Yu X, Liu H, Hamel KA, Morvan MG, Yu S, Leff J et al (2020) Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain. Nat Commun 11(1):264. https:\/\/doi.org\/10.1038\/s41467-019-13839-2","journal-title":"Nat Commun"},{"key":"4815_CR52","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052062","author":"M Da Vitoria Lobo","year":"2024","unstructured":"Da Vitoria Lobo M, Hardowar L, Valentine T, Tomblin L, Guest C, Sharma D et al (2024) Early-life cisplatin exposure induces neuroinflammation and chemotherapy-induced neuropathic pain. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.052062","journal-title":"Dis Model Mech"},{"key":"4815_CR53","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fnmol.2017.00397","volume":"10","author":"K Montague","year":"2017","unstructured":"Montague K, Malcangio M (2017) The therapeutic potential of monocyte\/macrophage manipulation in the treatment of chemotherapy-induced painful neuropathy. Front Mol Neurosci 10:397. https:\/\/doi.org\/10.3389\/fnmol.2017.00397","journal-title":"Front Mol Neurosci"},{"key":"4815_CR54","doi-asserted-by":"publisher","unstructured":"Lund H, Hunt MA, Kurtovic Z, Sandor K, Kagy PB, Fereydouni N et al (2024) CD163\u2009+\u2009macrophages monitor enhanced permeability at the blood-dorsal root ganglion barrier. J Exp Med 221(2). https:\/\/doi.org\/10.1084\/jem.20230675","DOI":"10.1084\/jem.20230675"},{"key":"4815_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12660","author":"AG Zippo","year":"2024","unstructured":"Zippo AG, Rodriguez-Menendez V, Pozzi E, Canta A, Chiorazzi A, Ballarini E et al (2024) Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy. J Peripher Nerv Syst. https:\/\/doi.org\/10.1111\/jns.12660","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"4815_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/0023677215575863","volume":"50","author":"H Naji-Esfahani","year":"2016","unstructured":"Naji-Esfahani H, Vaseghi G, Safaeian L, Pilehvarian AA, Abed A, Rafieian-Kopaei M (2016) Gender differences in a mouse model of chemotherapy-induced neuropathic pain. Lab Anim 50(1):15\u201320. https:\/\/doi.org\/10.1177\/0023677215575863","journal-title":"Lab Anim"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-025-04815-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04815-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:21:50Z","timestamp":1758720110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-025-04815-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4815"],"URL":"https:\/\/doi.org\/10.1007\/s00280-025-04815-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"90"}}